Skip to main content
Log in

L- and M2- pyruvate kinase expression in renal cell carcinomas and their metastases

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Using immunohistochemical and enzyme biochemical methods we investigated the expression of L- and M2-pyruvate kinase (PK) in normal renal tissue, renal cell carcinomas (RCCs; of clear cell, chromophilic cell and mixed cell type) and RCC metastases. L-PK was expressed in the proximal tubules of normal renal tissue and, to a variable extent, in 23/25 primary RCCs, in 1 RCC recurrence and in 10 RCC metastases. Staining intensity and percentage of stained tissue did not correlate with tumour grade. One renal oncocytoma and all extrarenal malignancies examined lacked L-PK immunoreactivity. M2-PK was mainly expressed in the distal tubules of the normal kidney and was found in all renal tumours as well as extrarenal malignancies. Quantitative biochemical investigations yielded a two- to seventeen-fold increase in PK activity in RCCs compared to the normal renal cortex taken from the same patient, whereas fructose-1,6-bisphosphatase and cytosolic glycerol-3-phosphate dehydrogenase activity was dramatically lower in RCCs. Otherwise, the activity of all other enzymes investigated (glucose-6-phosphate dehydrogenase, enolase and lactate dehydrogenase) was not significantly changed in the RCCs. The immunocytochemical results suggest that L-PK is a useful marker for RCC and its metastases, if acetone-fixed tissue is available. The quantitative changes of the concentration of PK and other enzymes in RCCs when compared with normal renal tissue probably reflect metabolic alterations related to tumour growth.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Ahn YS, Zerban H, Grobholz R, Bannasch P (1992) Sequential changes in glycogen content, expression of glucose transporters and enzymic patterns during development of clear/acidophilic cell tumors in rat kidney. Carcinogenesis 13:2329–2334

    Google Scholar 

  • Aithal HN, Toback FG, Cryst C (1980) Enhancement of renal medullary pyruvate kinase activity during cell proliferation induced by potassium depletion. Am J Physiol 238:377–388

    Google Scholar 

  • Ang LC, Debowski T, Michalski R (1991) Immunolocalization of prealbumin (transthyretin) in renal cell carcinoma. Histopathology 18:565–568

    Google Scholar 

  • Beckner ME, Stracke ML, Liotta LA, Schiffmann E (1990) Glycolysis as primary energy source in tumor cell chemotaxis. J Natl Cancer Inst 82:1836–1840

    Google Scholar 

  • Board M, Humm S, Newsholme EA (1990) Maximum activities of key enzymes of glycolysis, glutaminolysis, pentose phosphate pathway and tricarboxylic acid cycle in normal, neoplastic and suppressed cells. Biochem J 265:503–509

    Google Scholar 

  • Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KAF, Stein H, Mason DY (1984) Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32:219–229

    CAS  PubMed  Google Scholar 

  • Debruyne FMJ, Franssen MPH, Beniers A JMC, Schalken JA, Mulder PHM (1990) New prospects in the management of metastatic renal cell carcinoma. Experimental and clinical data. Prog Clin Biol Res 350:243–255

    Google Scholar 

  • Eigenbrodt E, Fister P, Reinacher M (1985) New perspectives on carbohydrate metabolism in tumor cells. In: Bettner R (ed) Regulation of carbohydrate metabolism. vol 2, CRC Press, Boca Raton, pp. 141–179

    Google Scholar 

  • Eigenbrodt E, Reinacher M, Scheefers-Borchel U, Scheefers H, Friis R (1992) Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells. Crit Rev Oncog 3:91–115

    Google Scholar 

  • Fischer G, Holzrichter S, Reinacher M, Heinrichs M, Dembowski J, Eigenbrodt E (1989) Immunhistochemische Darstellung der L- und M2-Pyruvatkinase in primären Nierenzellkarzinomen und deren Metastasen. Verh Dtsch Ges Pathol 73:422–427

    Google Scholar 

  • Fischer P, Störkel S, Haase W, Scherberich JE (1991) Differential diagnosis of histogenetically distinct human epithelial renal tumors with a monoclonal antibody against gamma-glutamyl-transferase. Cancer Immunol Immunother 33:382–388

    Google Scholar 

  • Gebracht U, Roth E, Becker K, Reinacher M, Eigenbrodt E (1988) A study of the activities of carbohydrate-metabolizing enzymes and the levels of carbohydrate metabolites and amino acids in normal liver and in hepatocellular carcinoma. In: Roberfroid MB, Preat V (eds) Experimental hepatocarcinogenesis, Plenum, pp. 163–174

  • Haas GP, Hillman GG, Redman BG, Pontes JE (1993) Immunotherapy of renal cell carcinoma. CA 43:177–187

    Google Scholar 

  • Haimoto H, Takashi M, Koshikawa T, Asai J, Kato K (1986) Enolase isozymes in renal tubules and renal cell carcinoma. Am J Pathol 124:488–495

    Google Scholar 

  • Hugo F, Mazurek S, Zander U, Eigenbrodt E (1992) In vitro effect of extracellular AMP on MCF-7 breast cancer cells: inhibition of glycolysis and cell proliferation. Cell Physiol 153:539–549

    Google Scholar 

  • Mazurek S, Scheefers-Borchel U, Scheefers H, Michel A, Basenau D, Fischer G, Dahlmann N, Laumen R, Eigenbrodt E (1993) Die Bedeutung der Pyruvatkinase in der Onkologie. notabene medici 3:97–104

    Google Scholar 

  • Nogueira E, Bannasch P (1988) Cellular origin of rat renal oncocytoma. Lab Invest 59:337–343

    Google Scholar 

  • Oosterwijk E, Ruiter DJ, Wakka JC, Huiskens van der Meij JW, Jonas U, Fleuren GJ, Zwartendijk J, Hoedemaeker PH, Warnaar SO (1986) Immunhistochemical analysis of monoclonal antibodies to renal antigens. Application in the diagnosis of renal cell carcinoma. Am J Pathol 123:301–309

    CAS  PubMed  Google Scholar 

  • Ortmann M, Vierbuchen M, Fischer R (1991) Sialylated glycoconjugates in chromophobe cell renal carcinoma compared with other renal cell tumours: indication of its development from the collecting duct epithelium. Virchows Arch [B] 61:123–132

    Google Scholar 

  • Quesada JR (1989) Role of interferons in the therapy of metastatic renal cell carcinoma. Urology 34 [suppl]:80–83

    Google Scholar 

  • Reinacher M (1983) Immunhistologischer Nachweis pathologischer Veränderungen des Pyruvatkinase-Enzymgehaltes in Organen und Tumoren bei Huhn und Ratte. Med Vet Habil-Schr Gießen

  • Reinacher M, Eigenbrodt E (1981) Immunohistological demonstration of the same type of pyruvate kinase isoenzyme (M2-PK) in tumors of chicken and rat. Virchows Arch [A] 37:79–88

    Google Scholar 

  • Rugarli C (1989) Progress in therapy of renal Cancer. Eur J Cancer Clin Oncol 25 [suppl 3]:519–523

    Google Scholar 

  • Stein H, Gatter K, Asbahr H, Mason DY (1985) Methods in laboratory investigation. Use of freeze-dried paraffin-embedded sections for immunohistologic staining with monoclonal antibodies. Lab Invest 52:676–683

    Google Scholar 

  • Steinberg P, Störkel S, Oesch F, Thoenes W (1992) Carbohydrate metabolism in human renal clear cell carcinomas. Lab Invest 67:506–511

    Google Scholar 

  • Störkel S (1993) Carcinomas and oncocytomas of the kidney: phenotypical characteristics and prognostic aspects. In: Denk H et al. (eds) Progress in pathology. Gustav Fischer, Stuttgart, pp 123–125

    Google Scholar 

  • Störkel S, Jakobi GH (1989) Systematik, Histogenese und Prognose der Nierenzellkarzinome und des renalen Onkozytoms des Menschen. Verh Dtsch Ges Pathol 73:321–338

    Google Scholar 

  • Störkel S, Steart PV, Drenckhahn D, Thoenes W (1989) The human chromophobe cell renal carcinoma: its probable relation to intercalated cells of the collecting duct. Virchows Arch [B] 56:237–245

    Google Scholar 

  • Thoenes W, Störkel ST, Rumpelt HJ (1986) Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. Pathol Res Pract 181:125–143

    Google Scholar 

  • Thoenes W, Störkel S, Rumpelt JH, Moll R, Baum HP, Werner S (1989) Chromophobe cell renal carcinoma and its variants — a report of 32 cases. J Pathol 155:277–287

    Google Scholar 

  • Vessella RL, Moon TD, Chiou RK, Nowak JA, Arfman EW, Palme DF, Peterson GA, Lange PH (1985) Monoclonal antibodies to human renal cell carcinoma: recognition of shared and restricted tissue antigens. Cancer Res 45:6131–6139

    Google Scholar 

  • Yoshida SO, Imam A (1989) Monoclonal antibody to a proximal nephrogenic renal antigen: immunohistochemical analysis of formalin-fixed, paraffin-embedded human renal cell carcionomas. Cancer Res 49:1802–1809

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brinck, U., Fischer, G., Eigenbrodt, E. et al. L- and M2- pyruvate kinase expression in renal cell carcinomas and their metastases. Vichows Archiv A Pathol Anat 424, 177–185 (1994). https://doi.org/10.1007/BF00193498

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00193498

Key words

Navigation